Theraclion SA (TCLIF)

Market Cap	10.59M
Revenue (ttm)	1.37M
Net Income (ttm)	-3.82M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	2,367
Open	0.320
Previous Close	n/a
Day's Range	0.320 - 0.320
52-Week Range	0.000 - 0.590
Beta	0.07
RSI	n/a
Earnings Date	Dec 27, 2024

About Theraclion

Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient’s skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 29
• Stock Exchange: OTCMKTS
• Ticker Symbol: TCLIF

Financial Performance

In 2023, Theraclion's revenue was 1.82 million, an increase of 47.49% compared to the previous year's 1.24 million. Losses were -3.68 million, -25.97% less than in 2022.

Financial numbers in EUR